The funding amount is one of the largest in recent years for an Indiana-based science startup.
Noblesville leaders expand scope of planned Innovation Mile
City leaders expect a stretch of undeveloped agricultural land on the city’s southeast side to become Hamilton County’s next epicenter of innovation.Read More
Elanco unveils plans for new ‘epicenter of animal health innovation’
Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.Read More
Cook Medical to sell reproductive health unit for $875M
The reproductive health unit includes products for obstetrics and gynecology, in vitro fertilization and assisted reproductive technology.Read More
Lilly signs deal with California biotech to develop treatments for Lou Gehrig’s disease
The collaboration could be worth as much as $694 million and potential royalties to Verge Genomics if the two companies hit development milestones.Read More
This year’s cohort for Gener8tor’s gBETA agbioscience accelerator includes companies working in everything from cold storage to aquaculture. The program wraps up later this month.
Three Indiana institutions are teaming up to try to develop a treatment for glioblastoma, a lethal cancer that begins with the brain or spinal cord, and is difficult to treat, often requiring a combination of surgery, chemotherapy and radiation.
Scientists said this full picture of the genome will give humanity a greater understanding of our evolution and biology while also opening the door to medical discoveries in areas like aging, neurodegenerative conditions, cancer and heart disease.
Fueled with a $36 million Lilly Endowment Inc. grant, the Central Indiana Corporate Partnership has launched AnalytiXIN to promote innovations in data science throughout Indiana.
Fishers-based Quantigen Biosciences is spending $2.5 million to redevelop 40,000 square feet of office space along Interstate 69 as its new specialty contract research laboratory.
The chemicals at issue are known as per- and polyfluoroalkyl substances, or PFAS. They include perfluorooctanoic acid, which was used in the production of Teflon, firefighting foam, water-repellent clothing and many other household and personal items.
CEO Jeff Simmons said the company’s high-profile downtown Indianapolis headquarters will signal a cultural transformation at the company, which for most of its six decades of existence operated as a little-noticed subsidiary of Eli Lilly and Co.
The ruling centers on AquaBounty’s salmon, which are genetically modified to grow faster than normal salmon. After clearing other regulatory hurdles. AquaBounty began growing the fish in indoor tanks at an Indiana plant last year.
The Fishers City Council on Monday approved two economic development deals that are expected to lead to a combined $96 million in investment.
The Indianapolis-based startup is developing drugs targeting brain and bowel disorders.
The innovation hub, expected to open early next year, is part of a $500 million, 50-acre campus along Indiana Avenue. The hub’s new name is a nod to the site’s history as the former Citizens Water headquarters.
A subsidiary of Swiss drug giant Novartis AG announced plans Tuesday to build a targeted radioligand therapy plant at Purdue Research Park near Indianapolis International Airport.
Attorney Angela Freeman, who has spent six years on the board of Women & Hi Tech, recommends using diverse committees—rather than leaving the job to one individual—for hiring and then assigning new employees, especially minority hires, to mentors who are invested in their success.
The pharmaceutical company said the Roundup settlement would “bring closure to approximately 75%” of the current 125,000 claims against subsidiary Monsanto.
Indianapolis-based Roche Diagnostics said Monday that it has begun shipping an initial order of 400,000 COVID-19 test kits to a network of more than 30 hospital and laboratories.
Large-scale testing is a critical part of tracking the spread of infectious diseases and allocating resources for treatment. The lack of comprehensive figures means U.S. health providers could quickly be overwhelmed by undetected cases.
The patient is from Hendricks County and attended a BioGenconference in Boston, where numerous other cases of COVID-19 have been reported.
The long-planned $500 million project is at a pivotal moment—one its organizers say could serve as a catalyst for tremendous growth at the 50-acre campus and for central Indiana overall.